HK1083635A1 - Animal protein free media for cultivation of cells - Google Patents

Animal protein free media for cultivation of cells

Info

Publication number: HK1083635A1
Authority: HK; Hong Kong
Prior art keywords: cells; animal protein; cultivation; protein free; free media
Prior art date: 2002-07-09

Application number

HK06103671A

Other languages

English (en)

Inventor

Manfred Reiter

Wolfgang Mundt

Leopold Grillberger

Barbara Kraus

Original Assignee

Baxter Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-09

Filing date

2006-03-23

Publication date

2006-07-07

2006-03-23 Application filed by Baxter Int filed Critical Baxter Int

2006-07-07 Publication of HK1083635A1 publication Critical patent/HK1083635A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/005—Protein-free medium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/74—Undefined extracts from fungi, e.g. yeasts
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Epidemiology (AREA)
Mycology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

HK06103671A 2002-07-09 2006-03-23 Animal protein free media for cultivation of cells HK1083635A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39424302P	2002-07-09	2002-07-09
PCT/EP2003/007341 WO2004005493A1 (en)	2002-07-09	2003-07-08	Animal protein free media for cultivation of cells

Publications (1)

Publication Number	Publication Date
HK1083635A1 true HK1083635A1 (en)	2006-07-07

Family

ID=30115698

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HK08101902A HK1108713A1 (en)	2002-07-09	2006-03-23	Animal protein free media for cultivation of cells
HK06103671A HK1083635A1 (en)	2002-07-09	2006-03-23	Animal protein free media for cultivation of cells

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HK08101902A HK1108713A1 (en)	2002-07-09	2006-03-23	Animal protein free media for cultivation of cells

Country Status (15)

Country	Link
US (3)	US7955833B2 (xx)
EP (2)	EP1520008B1 (xx)
JP (5)	JP2005532057A (xx)
CN (2)	CN101058800B (xx)
AU (1)	AU2003249990B2 (xx)
CA (1)	CA2491992A1 (xx)
DK (2)	DK2287288T3 (xx)
ES (2)	ES2398706T3 (xx)
HK (2)	HK1108713A1 (xx)
MX (1)	MXPA05000418A (xx)
NZ (1)	NZ538094A (xx)
PL (1)	PL214284B1 (xx)
PT (2)	PT1520008E (xx)
SI (1)	SI1520008T1 (xx)
WO (1)	WO2004005493A1 (xx)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6475725B1 (en)	1997-06-20	2002-11-05	Baxter Aktiengesellschaft	Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de)	1999-06-02	2002-07-25	Baxter Ag	Medium zur protein- und serumfreien kultivierung von zellen
US7425437B2 (en) *	1999-11-26	2008-09-16	Crucell Holland B.V.	Vaccines against West Nile Virus
FR2836924B1 (fr) *	2002-03-08	2005-01-14	Vivalis	Lignees de cellules aviaires utiles pour la production de substances d'interet
NZ538094A (en)	2002-07-09	2007-01-26	Baxter Int	Serum free and animal protein free culture medium for cultivation of cells
US7553665B2 (en) *	2004-03-01	2009-06-30	Ares Trading S.A.	Process for the cultivation of mammalian cells producing IL-18BP in serum-free cell culture medium
US8221969B2 (en)	2004-04-19	2012-07-17	Sanyo Chemical Industries, Ltd.	Method of producing virus
SI1789084T1 (sl) *	2004-09-09	2011-03-31	Novartis Vaccines & Diagnostic	Zmanjševanje potencialnih iatrogenih tveganj, povezanih z influenčnimi cepivi
AU2011221414B2 (en) *	2004-10-29	2012-09-20	Takeda Pharmaceutical Company Limited	Animal Protein-Free Media for Cultivation of Cells
US20060094104A1 (en)	2004-10-29	2006-05-04	Leopold Grillberger	Animal protein-free media for cultivation of cells
KR100679112B1 (ko)	2004-11-17	2007-02-07	삼성정밀화학 주식회사	동물세포 배양방법
AU2005322353B2 (en) *	2004-12-23	2011-09-01	Medimmune, Llc	Non-tumorigenic MDCK cell line for propagating viruses
WO2006095431A1 (ja)	2005-03-10	2006-09-14	Kyoritsu Seiyaku Corporation	動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
FR2884255B1 (fr)	2005-04-11	2010-11-05	Vivalis	Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CN101194165B (zh) *	2005-04-13	2013-01-09	梅瑞尔有限公司	猪圆环病毒的生产方法及监控生产的测定法
ATE507242T1 (de)	2005-05-12	2011-05-15	Crucell Holland Bv	Wirtszellenspezifische bindungsmoleküle, die dazu in der lage sind, viren zu neutralisieren, und anwendungen davon
JP2007000077A (ja) *	2005-06-23	2007-01-11	Hitachi Medical Corp	付着性動物細胞の無血清培養方法及び付着性動物細胞の無血清培養用培地
PT2522717E (pt)	2006-01-04	2014-05-15	Baxter Healthcare Sa	Meios de cultura celulares livres de oligopeptídeos
US9254318B2 (en)	2006-03-31	2016-02-09	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses for vaccines
US7767451B2 (en)	2006-04-28	2010-08-03	Kyoritsu Seiyaku Corporation	Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof
NZ572773A (en) *	2006-06-06	2011-11-25	Crucell Holland Bv	Human binding molecules having killing activity against staphylococci and uses thereof
RU2473688C2 (ru) *	2006-08-09	2013-01-27	Вивалис	Способ получения трансгенных птиц с использованием эмбриональных стволовых клеток
MX2009002741A (es)	2006-09-15	2009-05-11	Medimmune Llc	Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas.
TW200902708A (en)	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
EP1985305A1 (en)	2007-04-24	2008-10-29	Vivalis	Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) *	2007-05-21	2008-11-26	Vivalis	Recombinant protein production in avian EBx® cells
WO2008156778A2 (en)	2007-06-18	2008-12-24	Tokiko Watanabe	Influenza m2 protein mutant viruses as live influenza attenuated vaccines
ES2657055T3 (es) *	2007-08-09	2018-03-01	Wyeth Llc	Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
BR122019022434B8 (pt) *	2007-12-27	2021-07-27	Baxalta GmbH	método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
WO2009088713A1 (en) *	2007-12-31	2009-07-16	Baxter International Inc.	Substantially animal protein-free recombinant furin and methods for producing same
KR101220239B1 (ko) *	2008-04-01	2013-01-09	바이오스펙트럼 주식회사	식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
TW201012930A (en)	2008-06-16	2010-04-01	Intervet Int Bv	Method of replicating viruses in suspension
AU2009296701B2 (en)	2008-09-24	2015-02-19	Medimmune, Llc	Methods for cultivating cells, propagating and purifying viruses
WO2011011660A2 (en) *	2009-07-23	2011-01-27	Xcellerex, Inc.	Drain down and re-feed of microcarrier bioreactor
EP2493912B1 (en)	2009-10-26	2020-07-29	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses with enhanced replication in vero cells
US10130697B2 (en)	2010-03-23	2018-11-20	Wisconsin Alumni Research Foundation (Warf)	Vaccines comprising mutant attenuated influenza viruses
CN101988047B (zh) *	2010-05-13	2013-07-03	维亚生物科技(上海)有限公司	一种低成本的昆虫细胞无血清培养基
CN102533634A (zh) *	2012-02-22	2012-07-04	江阴剑桥生物技术有限公司	Cho细胞无血清无蛋白化学培养基
WO2015009743A1 (en)	2013-07-15	2015-01-22	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
GB201321679D0 (en) *	2013-12-09	2014-01-22	Vibralogics Gmbh	Method of culturing vero cells
US10527551B2 (en)	2013-12-30	2020-01-07	Baxalta Incorporated	Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use
EP4372078A3 (en)	2014-06-04	2024-09-04	Amgen Inc.	Methods for harvesting mammalian cell cultures
WO2015196150A2 (en)	2014-06-20	2015-12-23	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to additional genes in influenza viruses
CN105385661B (zh) *	2014-09-03	2019-02-05	普莱柯生物工程股份有限公司	一种猪圆环病毒2型大规模培养的方法及其应用
US10633422B2 (en)	2015-06-01	2020-04-28	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
US9890363B2 (en)	2015-07-06	2018-02-13	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication for vaccine development
CN105154389A (zh) *	2015-10-15	2015-12-16	南京三生生物技术有限公司	一种适于pk-15细胞生长的低血清无蛋白培养基及其制备方法
EP3417056A1 (en)	2016-02-19	2018-12-26	Wisconsin Alumni Research Foundation (WARF)	Improved influenza b virus replication for vaccine development
EP3372671B1 (en) *	2017-03-09	2021-11-03	Evonik Operations GmbH	Culture medium comprising olgopeptides
CN107043740A (zh) *	2017-05-10	2017-08-15	浙江美保龙生物技术有限公司	一种mdbk细胞培养液及其制备方法、使用方法
US11197926B2 (en)	2017-10-25	2021-12-14	Wisconsin Alumni Research Foundation (Warf)	Recombinant influenza viruses with stabilized HA for replication in eggs
EP3840780A1 (en)	2018-08-20	2021-06-30	Wisconsin Alumni Research Foundation	Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
WO2020106975A1 (en) *	2018-11-21	2020-05-28	Western Oncolytics Ltd.	Manufacture of virus
MX2021006115A (es) *	2019-01-17	2021-07-07	Boehringer Ingelheim Animal Health Usa Inc	Medio libre de suero para produccion de vacuna aviar y usos del mismo.
US11241492B2 (en)	2019-01-23	2022-02-08	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to genes in influenza viruses
WO2020153619A1 (ko) *	2019-01-25	2020-07-30	바이로큐어 주식회사	Bhk-21 세포를 이용한 바이러스 생산방법
WO2020163804A1 (en)	2019-02-08	2020-08-13	Wisconsin Alumni Research Foundation (Warf)	Humanized cell line
CN114929269A (zh)	2019-05-01	2022-08-19	威斯康星校友研究基金会(Warf)	用于疫苗开发的改进的流感病毒复制
WO2021041624A2 (en)	2019-08-27	2021-03-04	Yoshihiro Kawaoka	Recombinant influenza viruses with stabilized ha for replication in eggs
MX2022009132A (es) *	2020-01-24	2022-08-22	Air Protein Inc	Hidrolizados de proteina derivados de microorganismos, y metodos de preparacion y uso de los mismos.
WO2022103252A1 (en) *	2020-11-12	2022-05-19	Imu Education Sdn Bhd	Culture medium for bacteria
KR102581772B1 (ko) *	2021-03-30	2023-09-22	강원대학교 산학협력단	식물 및 곤충 단백질 가수 분해물을 이용한 배양육 제조를 위한 최적 배양 방법 및 그 응용
IL317136A (en) *	2022-06-03	2025-01-01	Bluerock Therapeutics Lp	Cell delivery device and methods of use thereof

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT165999B (de)	1947-06-26	1950-05-25	Delle Atel Const Electr	Einirchtung zum Schutz von Drehstrommotoren gegen Überstrom
FR2196386A1 (en)	1972-08-17	1974-03-15	Cudennec Alain	Culture media selection - for identification of unknown bacteria
US4500513A (en) *	1979-05-15	1985-02-19	Miles Laboratories, Inc.	Influenza vaccine production in liquid cell culture
US4282315A (en) *	1979-09-13	1981-08-04	Corning Glass Works	Preparation of enriched whole virus radioligand
US4443540A (en)	1980-05-09	1984-04-17	University Of Illinois Foundation	Protein hydrolysis
DK207980A (da)	1980-05-13	1981-11-14	Novo Industri As	Fremgangsmaade til fremstilling af et skumnings- eller emulgeringsmiddel paa sojaproteinbasis
DE3122669A1 (de) *	1980-06-12	1982-02-11	Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld	"verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
US4767704A (en)	1983-10-07	1988-08-30	Columbia University In The City Of New York	Protein-free culture medium
NZ210501A (en)	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
CH652378A5 (de)	1983-12-21	1985-11-15	Heinrich Nagel Ag Wislikofen	Einrichtung zum absaugen und zerkleinern von in einem gasfoermigen medium foerderbarem material.
IL74909A (en)	1984-04-20	1992-01-15	Genentech Inc	Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
EP0217822B1 (en)	1985-02-13	1993-05-12	Scios Nova Inc.	Human metallothionein-ii promoter in mammalian expression system
US4978616A (en)	1985-02-28	1990-12-18	Verax Corporation	Fluidized cell cultivation process
EP0318487B1 (en)	1986-08-04	1993-10-13	The University Of New South Wales	Serum free tissue culture medium containing polymeric cell-protective agent
US4710282A (en)	1986-08-08	1987-12-01	Maryan Chak	Device for siliverizing running water
EP0364481A4 (en) *	1987-06-18	1992-01-22	Monash University	Growth factors
WO1989000192A1 (en)	1987-06-30	1989-01-12	Amgen Inc.	Production of kallikrein
JP2507882B2 (ja)	1988-02-17	1996-06-19	工業技術院長	外部増殖因子非依存性増殖良好細胞株の製造法
JPH01211878A (ja)	1988-02-19	1989-08-25	Fujitsu Ltd	Ｉ／ｏピンの修復方法
US6048728A (en)	1988-09-23	2000-04-11	Chiron Corporation	Cell culture medium for enhanced cell growth, culture longevity, and product expression
US5573937A (en)	1989-12-07	1996-11-12	Snow Brand Milk Products Co., Ltd.	Serum free culture medium
SE465222C5 (sv)	1989-12-15	1998-02-10	Pharmacia & Upjohn Ab	Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
WO1991010726A1 (en)	1990-01-22	1991-07-25	The United States Of America, Represented By The Secretary, United States Department Of Commerce	Co-independent growth medium for maintenance and propagation of cells
JP2844484B2 (ja)	1990-02-22	1999-01-06	味の素株式会社	組換え蛋白質の生産方法
JP2859679B2 (ja)	1990-03-01	1999-02-17	協和醗酵工業株式会社	新規細胞株
US5378612A (en)	1990-05-11	1995-01-03	Juridical Foundation The Chemo-Sero-Therapeutic Research Institute	Culture medium for production of recombinant protein
JP2696001B2 (ja)	1991-04-15	1998-01-14	財団法人化学及血清療法研究所	組換え蛋白質産生用培地
US5122469A (en)	1990-10-03	1992-06-16	Genentech, Inc.	Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
JPH04228066A (ja)	1990-10-23	1992-08-18	Rikagaku Kenkyusho	外来遺伝子発現用培養細胞
US5213795A (en) *	1990-10-24	1993-05-25	Oxford	Encephalomyocarditis virus vaccine
EP0531562A1 (de)	1991-09-11	1993-03-17	Doerr, Hans-Wilhelm, Prof. Dr. med.	Kultivierung von Säugetierzellen
JPH05123178A (ja)	1991-11-01	1993-05-21	Ajinomoto Co Inc	Ｌ−フエニルアラニンの製造法
JP3511399B2 (ja) *	1993-03-31	2004-03-29	株式会社三菱化学ヤトロン	細胞培養基材及び細胞培養方法
DE4313620A1 (de)	1993-04-26	1994-10-27	Biotechnolog Forschung Gmbh	Hamsterzellinien und Verfahren zur Glykoproteingewinnung
AU7895898A (en)	1993-04-26	1998-10-08	Hans Wolf	Mammal cell lines and method of obtaining glycoproteins
US5405637A (en)	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
JP4098372B2 (ja)	1993-07-28	2008-06-11	三菱化学株式会社	ヘパリン結合性増殖因子の生産方法
JP2766165B2 (ja)	1993-08-02	1998-06-18	株式会社バイオポリマー・リサーチ	バクテリアセルロースの製造方法
US5833162A (en) *	1993-12-22	1998-11-10	Daewoo Electronics Co., Ltd.	Reel table driving device for a video cassette recorder
US5719050A (en)	1993-12-24	1998-02-17	Eiken Chemical Co., Ltd.	Animal cell culturing media containing N-acetyl-L-glutamic acid
EP0666312A1 (en)	1994-02-08	1995-08-09	Wolfgang A. Renner	Process for the improvement of mammalian cell growth
US5789247A (en)	1994-04-01	1998-08-04	Ballay; Annick	Expression in non-tumoral human lymphoblastoid lines with an integrative vector
EP0733100A1 (de)	1994-09-09	1996-09-25	Wolfgang A. Renner	Chemisches verfahren zur förderung der proliferation von tierischen zellen
EP2290053A1 (en) *	1994-11-10	2011-03-02	Baxter Healthcare S.A.	Method for producing Influenza virus in protein-free cell culture medium
US5753489A (en) *	1994-11-10	1998-05-19	Immuno Ag	Method for producing viruses and vaccines in serum-free culture
AT403167B (de)	1994-11-14	1997-11-25	Immuno Ag	Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems
JP3244391B2 (ja)	1994-12-08	2002-01-07	財団法人国際超電導産業技術研究センター	複合基板及びそれを用いた単結晶基板の製造方法
WO1996018734A1 (en)	1994-12-16	1996-06-20	Novartis Ag	Production of recombinant secretory component
US5741705A (en)	1995-02-23	1998-04-21	Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc.	Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides
EP0811056B1 (en)	1995-02-23	2000-05-31	Quest International B.V.	Peptides for tissue and cell culture media
AU6125396A (en)	1995-06-07	1996-12-30	Novartis Ag	Serum-free media for primitive hematopoietic cells and metho ds of use thereof
US5942386A (en)	1995-06-07	1999-08-24	Thomas Jefferson University	Anti-fungal agents and methods of identifying and using the same
AUPN442295A0 (en)	1995-07-26	1995-08-17	Commonwealth Scientific And Industrial Research Organisation	Regulated autocrine growth of mammalian cells
US5851800A (en)	1996-05-14	1998-12-22	Pharmacia & Upjohn Ab	Process for producing a protein
JP2000517188A (ja)	1996-08-30	2000-12-26	ライフテクノロジーズ，インコーポレイテッド	無血清哺乳動物細胞培養培地およびその使用
EP0954563B1 (en)	1996-10-10	2008-07-02	Invitrogen Corporation	Animal cell culture media comprising plant-derived nutrients
US5804420A (en)	1997-04-18	1998-09-08	Bayer Corporation	Preparation of recombinant Factor VIII in a protein free medium
EP1849860B1 (en)	1997-05-28	2010-11-17	Novartis Vaccines and Diagnostics S.r.l.	Process for preparing an immunogenic factor of Corynebacterium diphtheriae using a culture medium with yeast extract as aminoacid source and no protein complexes of animal origin
US6475725B1 (en)	1997-06-20	2002-11-05	Baxter Aktiengesellschaft	Recombinant cell clones having increased stability and methods of making and using the same
AT407255B (de)	1997-06-20	2001-02-26	Immuno Ag	Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
TR200000175T2 (tr)	1997-07-23	2001-01-22	Roche Diagnostics Gmbh	Endogenik gen aktivasyonu ile eritropoietinin hazırlanması.
JPH11211488A (ja)	1998-01-21	1999-08-06	Matsushita Electric Ind Co Ltd	携帯情報端末を用いたデータ転送システム
FR2775983B1 (fr)	1998-03-13	2000-11-10	Pasteur Merieux Serums Vacc	Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en)	1998-05-01	1999-11-11	Life Technologies, Inc.	Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) *	1998-07-10	2002-06-18	Chugai Seiyaku Kabushiki Kaisha	Serum-free medium for culturing animal cells
AT409379B (de)	1999-06-02	2002-07-25	Baxter Ag	Medium zur protein- und serumfreien kultivierung von zellen
DE59913565D1 (de)	1999-08-05	2006-07-27	Baxter Ag	Rekombinanter stabiler zellklon, seine herstellung und verwendung
ES2272318T3 (es)	1999-08-25	2007-05-01	Immunex Corporation	Composiciones y metodos para el cultivo celular mejorado.
US7425437B2 (en) *	1999-11-26	2008-09-16	Crucell Holland B.V.	Vaccines against West Nile Virus
JP2001211878A (ja) *	2000-02-04	2001-08-07	National Federation Of Dairy Cooperative Associations	ヨーグルトスターター乳酸菌の高濃度培養方法、及び得られた高濃度培養液を用いたヨーグルトの製造方法
CN1582333B (zh)	2000-09-25	2010-06-16	波利门科学生物免疫研究有限公司	活疫苗及生产方法
EP1208966A1 (en)	2000-11-27	2002-05-29	Cheng-Kun Liao	Manufacturing process of patio tabletop glass with broken protection
NZ538094A (en)	2002-07-09	2007-01-26	Baxter Int	Serum free and animal protein free culture medium for cultivation of cells
JP4316484B2 (ja)	2004-12-10	2009-08-19	シャープ株式会社	画像形成装置、トナー濃度制御方法、トナー濃度制御プログラムおよびその記録媒体

2003
- 2003-07-08 NZ NZ538094A patent/NZ538094A/en not_active IP Right Cessation
- 2003-07-08 CN CN2007101019058A patent/CN101058800B/zh not_active Expired - Lifetime
- 2003-07-08 PL PL374782A patent/PL214284B1/pl unknown
- 2003-07-08 PT PT03762657T patent/PT1520008E/pt unknown
- 2003-07-08 ES ES10010584T patent/ES2398706T3/es not_active Expired - Lifetime
- 2003-07-08 US US10/614,037 patent/US7955833B2/en not_active Expired - Lifetime
- 2003-07-08 CA CA 2491992 patent/CA2491992A1/en not_active Abandoned
- 2003-07-08 DK DK10010584T patent/DK2287288T3/da active
- 2003-07-08 WO PCT/EP2003/007341 patent/WO2004005493A1/en active IP Right Grant
- 2003-07-08 EP EP20030762657 patent/EP1520008B1/en not_active Expired - Lifetime
- 2003-07-08 ES ES03762657T patent/ES2394085T3/es not_active Expired - Lifetime
- 2003-07-08 CN CN03821326A patent/CN100591759C/zh not_active Expired - Lifetime
- 2003-07-08 SI SI200332208T patent/SI1520008T1/sl unknown
- 2003-07-08 MX MXPA05000418A patent/MXPA05000418A/es active IP Right Grant
- 2003-07-08 JP JP2004518745A patent/JP2005532057A/ja not_active Withdrawn
- 2003-07-08 EP EP20100010584 patent/EP2287288B1/en not_active Expired - Lifetime
- 2003-07-08 PT PT100105840T patent/PT2287288E/pt unknown
- 2003-07-08 DK DK03762657T patent/DK1520008T3/da active
- 2003-07-08 AU AU2003249990A patent/AU2003249990B2/en not_active Expired
2006
- 2006-03-23 HK HK08101902A patent/HK1108713A1/xx unknown
- 2006-03-23 HK HK06103671A patent/HK1083635A1/xx unknown
2010
- 2010-11-29 JP JP2010265835A patent/JP5485863B2/ja not_active Expired - Lifetime
2011
- 2011-05-06 US US13/102,765 patent/US8524497B2/en not_active Expired - Lifetime
- 2011-11-25 JP JP2011258106A patent/JP6084359B2/ja not_active Expired - Lifetime
2013
- 2013-05-10 JP JP2013100500A patent/JP6178109B2/ja not_active Expired - Lifetime
- 2013-08-06 US US13/960,481 patent/US9163211B2/en not_active Expired - Lifetime
2014
- 2014-12-03 JP JP2014245252A patent/JP6244294B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1520008T1 (sl)	2012-12-31
EP1520008B1 (en)	2012-09-05
ES2394085T3 (es)	2013-01-17
CN100591759C (zh)	2010-02-24
CA2491992A1 (en)	2004-01-15
JP5485863B2 (ja)	2014-05-07
MXPA05000418A (es)	2005-03-23
PL374782A1 (en)	2005-10-31
HK1108713A1 (en)	2008-05-16
AU2003249990A1 (en)	2004-01-23
EP2287288B1 (en)	2012-11-07
US20110217772A1 (en)	2011-09-08
JP2005532057A (ja)	2005-10-27
CN1681917A (zh)	2005-10-12
EP2287288A1 (en)	2011-02-23
WO2004005493A1 (en)	2004-01-15
PT2287288E (pt)	2012-12-10
JP2015083005A (ja)	2015-04-30
JP6084359B2 (ja)	2017-02-22
JP2011041580A (ja)	2011-03-03
CN101058800A (zh)	2007-10-24
PL214284B1 (pl)	2013-07-31
US8524497B2 (en)	2013-09-03
JP2013172741A (ja)	2013-09-05
JP2012034712A (ja)	2012-02-23
ES2398706T3 (es)	2013-03-21
US9163211B2 (en)	2015-10-20
US7955833B2 (en)	2011-06-07
JP6244294B2 (ja)	2017-12-06
US20040077086A1 (en)	2004-04-22
PT1520008E (pt)	2012-09-26
JP6178109B2 (ja)	2017-08-09
CN101058800B (zh)	2013-03-13
EP1520008A1 (en)	2005-04-06
AU2003249990B2 (en)	2007-06-28
US20130316434A1 (en)	2013-11-28
DK2287288T3 (da)	2013-01-07
NZ538094A (en)	2007-01-26
DK1520008T3 (da)	2012-10-15

Publication	Publication Date	Title
HK1083635A1 (en)	2006-07-07	Animal protein free media for cultivation of cells
EP2199382A3 (en)	2010-09-22	Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
MXPA05009096A (es)	2005-10-19	Metodo de cultivo celular libre de animal.
ATE399855T1 (de)	2008-07-15	Tierzellkulturmedium mit pflanzlichen nährstoffen
WO2005066204A3 (en)	2005-08-11	Neutralizing epitope-based growth enhancing vaccine
HK1056197A1 (en)	2004-02-06	Heterologous expression of neisserial proteins.
HUP0301659A2 (hu)	2003-08-28	Kukorica cellulóz-szintetázok és alkalmazásuk
AU2002336930A1 (en)	2003-02-17	Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
DK0956338T3 (da)	2006-05-08	Værtsceller og fremgangsmåder til produktion af proteiner
DE602005022387D1 (de)	2010-09-02	Verfahren zur Herstellung von Dipeptiden
ATE361360T1 (de)	2007-05-15	Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
WO2005024038A3 (en)	2005-12-29	Process for producing a capsular polysaccharide for use in conjugate vaccines
WO2001005997A3 (en)	2001-07-26	Method for production of tetanus toxin using media substantially free of animal products
DE60331224D1 (de)	2010-03-25	Subtilisin-carlsberg-proteine mit verminderter immunogenität
AU4940096A (en)	1996-10-08	Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
BRPI0507347B8 (xx)	2021-05-25
NO20050721D0 (no)	2005-02-10	HSP70 fra Artherobacter
AU2003246369A1 (en)	2003-12-31	Vaccination with immuno-isolated cells producing an immunomodulator
HUP0101081A2 (hu)	2001-07-30	Tápközeg és eljárás vírustenyésztésre és szaporításra
DK1334197T3 (da)	2011-04-04	Gær-afledt vaccine mod IPNV
AU2003206926A1 (en)	2003-09-09	Cultivation method for micro-organisms and bioreactor
EP1762609A3 (en)	2007-05-02	Serum-free medium for producing substances of interest
WO2003061675A8 (en)	2004-04-29	Biologically active additive to food and method for producing said additive
WO2001062066A3 (en)	2002-03-21	For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture
GR1004521B (el)	2004-04-06	ΜΕΘΟΔΟΣ ΑΠΟΜΟΝΩΣΗΣ ΚΑΙ ΠΑΡΑΓΩΓΗΣ ΤΗΣ ΠΡΩΤΕΙΝΗΣ ΚΟΛΛΑΓΕΝΑΣΗ 3ie ΧΡΗΣΙΜΟΠΟΙΩΝΤΑΣ ΩΣ ΠΡΩΤΗ ΥΛΗ ΤΟ ΗΠΑΤΟΠΑΓΚΡΕΑΣ ΤΩΝ ΚΑΒΟΥΡΙΩΝ ΤΗΣ ΚΑΜΤΣΑΤΚΑΣ (PARALITHODES CAMTSCHATICA)